PABPC1P4

Across TCGA pan-cancer cohorts, PABPC1P4 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated PABPC1P4 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher PABPC1P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PABPC1P4 expression acts as an unfavorable survival marker, although some lineages such as SKCM and COAD show a favorable association.

STAD, OV, and SKCM are the cancer types where PABPC1P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Median	All	0.460	0.611	.011	45	view →
OV	OS	Median	All	0.258	0.369	<.001	38	view →
SKCM	OS	Quartile	III,IV	0.608	0.343	.001	33	view →
COAD	OS	Tertile	All	0.868	0.510	.003	31	view →
KIRC	DFS	Quartile	III,IV	0.626	0.339	.001	28	view →
KIRP	DFS	Median	IV	0.039	0.593	.008	24	view →
HNSC	DFS	Tertile	IV	0.505	0.283	.004	21	view →
BLCA	DFS	Quartile	III,IV	0.662	0.471	.004	21	view →
UCS	DFS	Median	IV	0.909	0.416	.008	18	view →
SARC	OS	Quartile	All	0.886	0.629	.002	17	view →
BRCA	OS	Median	III,IV	0.630	0.453	.014	16	view →
ESCA	OS	Quartile	III,IV	0.791	0.389	.004	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

PABPC1P4–STAD (DFS)

Open the STAD breakdown →